HOW TO PLAY IT

According to Dan Ahrens

Don’t be tempted by Canadian cannbis stocks, says Dan Ahrens, manager of AdvisorShares’ Pure Cannabis ETF: The best pot stocks are homegrown in the USA. His top pick is Massachusettsbased Curaleaf, whose 90-plus dispensaries in 23 states make it the largest in a growing crop of multistate marijuana operators. Ahrens, whose fund is up 47% in the last 12 months, points

out that Curaleaf is still legally prohibited from listing its shares on U.S. exchanges like Nasdaq and NYSE, so it trades over the counter and is less popular with investors than Canadian cannabis merchants like Nasdaq-listed Tilray. In 2021, Curaleaf is expected to break even after losing $52 million on revenue of $472

million over the past 12 months. By contrast, Tilray is burning through its stash, losing $487

million on $201 million in revenue. Ahrens expects Curaleaf to be a big winner as more states legalize recreational

cannabis.

Dan Ahrens is chief operating

officer of AdvisorShares and portfolio manager of Pure

Cannabis ETF.